Yaoming H. Xue
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Keluoxin inhibits the progression of diabetic kidney disease via TNF-α/IKKβ/IκBα/NF-κB p65 signaling pathway.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: July 10, 2026
Triple oral therapy with metformin, DPP-4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025).
Journal: Diabetes, obesity & metabolism
Published: September 23, 2025
Synergistic effects of Akebia saponin D and Semaglutide on diabetic nephropathy and osteoporosis via the Klotho‑p53 signaling axis.
Journal: International journal of molecular medicine
Published: July 03, 2025
Melatonin attenuates kidney injury by alleviating lysosomal damage in diabetic kidney disease.
Journal: Acta biochimica et biophysica Sinica
Published: June 13, 2025
Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial.
Journal: BMJ (Clinical research ed.)
Published: June 04, 2025
Burosumab in Chinese adults with X-linked hypophosphatemia: a phase 4 study.
Journal: JBMR plus
Published: March 31, 2025
Comparative performance of multiple inflammatory indices across different stages of cardiovascular-kidney-metabolism syndrome: A Multi-Cohort Study.
Journal: Endocrine
Published: March 01, 2025
Relationship between moderate alcohol consumption and all-cause mortality across different stages of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: a cohort study.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: February 21, 2025
Adherence to blood glucose self-monitoring guidance and glycemic control in Chinese patients with type 2 diabetes mellitus initiating basal insulin: A mobile health-based prospective cohort study.
Journal: Chinese medical journal
Published: February 05, 2025
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial.
Journal: BMJ (Clinical research ed.)
Published: January 22, 2025
SESN2 inhibits tubular exosome secretion and diabetic kidney disease progression by restoring the autophagy‒lysosome pathway.
Journal: International journal of biological sciences
Published: January 03, 2025
Last Updated: 09/26/2026